The NIS-Child was the first of the NIS, launched in 1994. The target population for the NIS-Child is children who are or will be 19-35 months within a few weeks of being selected to participate in the survey and living in the United States. Data are used to monitor vaccination coverage among 2-year-old children at the national, state, selected local levels, and some in U.S. territories.

The NIS-Child measures coverage of the following recommended vaccinations:

• Diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP/DT/DTP)
• Poliovirus vaccine (Polio)
• Measles or Measles-Mumps-Rubella vaccine (MMR)
• Haemophilus influenzae type b vaccine (Hib)
• Hepatitis B vaccine (HepB)
• Varicella zoster (chickenpox) vaccine (VAR)
• Pneumococcal conjugate vaccine (PCV)
• Rotavirus vaccine (ROT)
• Hepatitis A vaccine (HepA)
• Influenza vaccine (Flu)

View Texas-specific results for Children.

The NIS-Teen was launched in 2006. The target population for the NIS-Teen is adolescents 13–17 years living in the United States at the time of the interview. Data are used to monitor vaccination coverage among teens at the national, state, and selected local levels, and some in U.S. territories.

The NIS-Teen includes coverage of the following routine adolescent vaccines:

• Tetanus, diphtheria, acellular pertussis (Tdap)
• Meningococcal conjugate (MenACWY)
• Human papillomavirus (HPV)
• Influenza vaccine (Flu)

View Texas-specific results for Teens.

The flu vaccination questions in the NIS-CIM are also included in the NIS and NIS-Teen. The NIS-Flu combines the flu vaccination responses collected from NIS (children 19–35 months), NIS-Teen (adolescents 13–17 years), and NIS-CIM (children 6–18 months and 3–12 years).  NIS-Flu data are used to assess annual flu vaccination coverage among children 6 months–17 years at the national, state, and selected local levels, some in U.S. territories.  These NIS-Flu estimates are based on the parent or guardian-reported data.

View Texas-specific results for Flu.